Digital Rectal Exam in Prostate Cancer Screening and Elevated PSA Work-up-Is there a role anymore?

Area of Science:

• Urology
• Oncology
• Diagnostic Imaging

Background:

• Prostate cancer (PCa) screening methods, including digital rectal examination (DRE), are subject to ongoing evaluation.
• The effectiveness of DRE as a standalone screening tool for PCa is being questioned.

Purpose of the Study:

• To critically assess the utility and accuracy of digital rectal examination (DRE) in prostate cancer (PCa) screening.
• To review current evidence on the role of DRE in conjunction with other screening modalities like PSA and MRI.

Main Methods:

• Systematic review of recent studies on DRE, PSA, and MRI in prostate cancer screening.
• Analysis of data regarding sensitivity, specificity, and detection rates for clinically significant PCa (CSPC).

Main Results:

• DRE alone demonstrates limited accuracy for PCa screening, leading to missed diagnoses and unnecessary biopsies.
• Combining PSA with DRE marginally increases CSPC detection but with questionable clinical benefit.
• MRI shows high accuracy for identifying CSPC, with potential as a superior screening tool, though direct comparisons with DRE are limited.

Conclusions:

• The role of DRE in current prostate cancer screening is limited.
• Emerging evidence suggests MRI may offer a more effective screening approach than DRE.
• Further research is needed to directly compare MRI with DRE for PCa screening.